0

Close
 
Upcoming Allied Market Research
2023
Nephrostomy Device Market

Nephrostomy Device Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Medical Devices & Supplies
Report Code: A11219
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nephrostomy Device Market

Request Now !

A nephrostomy is a thin, plastic tube (catheter) that is inserted through the skin on from the back and into your kidney. Certain patients may have a catheter into each kidney. This drains urine from one or even both of the kidneys into a collecting bag outside the individual's body. Furthermore, the bag has a tap so that one can easily empty it. It is also possible that the individual passes the urine in the normal way even if the nephrostomy tube is kept inserted in one, or both the kidneys. This placement of the stent in the ureter is carried out with the assistance of the image-guidance by the physicians. One of the types is Percutaneous nephrostomy, which is performed in the cases of failure of placement of the ureteral stent, to help restore the flow of urine. This allows a rise in demand for nephrostomy devices, which are extensively used for the treatment of hydronephrosis. Ureters may become obstructed due to certain conditions such as blood clots, tumors, kidney stones, and infection, causing the blockage of urine flow. Therefore, ureteral stents and nephrostomy devices are in general used to restore urine flow and ensure that it passes through the blocked ureters, which allows the kidney to function normally.

COVID-19 scenario analysis:

The infected population requires medical supplies such as atomizer, life-support machine, oxygen generator, and monitor for sustaining. The growth in the number of individuals having COVID-19 is also boosting the need for the respiratory support devices and hence is anticipated to boost the medical supplies market in the coming years. These are majorly used medical devices in primary clinical treatment. Furthermore, COVID-19 has led to a rise demand for medical supplies that can be used to prevent the spread of infection such as personal protective equipment including masks, gloves, and protective eyeglasses. Both healthcare professionals and civil population need these personal protective equipment in order to ensure that the precautionary measures are taken care of. Manufacturers of these medical devices have a chance to gain maximum revenue in the near future.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the industry includes increase in prevalence of urological diseases such as bladder obstruction, kidney stones, urinary retention, bladder cancer, prostate cancer and hydronephrosis, which would boost the industry in the forecast period. The surge in the number of procedures for percutaneous nephrostomy, is also expected to propel the Nephrostomy Device market in the next few years.  The surge in demand for minimally invasive procedures and growth in awareness for availing better quality of life would help the market flourish in the coming years. However, the stringent regulations may impede the growth of the Nephrostomy Device market in the commenced period.

New product advancements to flourish the market

In February 2017, Cook Medical has rounded out the Universal line with the introduction of two new sets for percutaneous urinary drainage. Each set includes a catheter and accessories for specific procedures. These sets streamline Cook’s offering of percutaneous drainage products.

In September 2018, Boston Scientific Corporation announced the global launch of the LithoVue Empower Retrieval Deployment Device, designed to be utilized with the LithoVue Single-Use Digital Flexible Ureteroscope and compatible nitinol retrieval basket to enable urologists to operate an ureteroscope and basket simultaneously when retrieving kidney stones via flexible ureteroscopy (URS). The LithoVue Empower Device is one of the several new devices Boston Scientific is planning that addresses unmet needs and inefficiencies during stone procedures through innovation. 

Surge in incidences of disease which needs nephrostomy devices for management to boost the market

According to the estimates given by the National Kidney Foundation, the lifetime risk of kidney stones is approximately 19% in men and 9% in women. Furthermore, in men, the first episode is expected to occur after age 30, but it can occur earlier. Other diseases such as diabetes, high blood pressure, and obesity may increase the risk for kidney stones.

According to the estimations of Center of disease Control and Prevention, the precise number of people who are affected by DVT/PE (also called venous thromboembolism) are expected to be 900,000 people and about (1 to 2 per 1,000) each year in the U.S. Furthermore, the estimates suggest that 60,000-100,000 Americans die of DVT/PE. Surge in number of people experiencing blood clots may lead to the blockage of ureters, hence the need for the nephrostomy devices for assistance in the management would propel the market growth during the forecast period

Key benefits of the report:

  • This study presents the analytical depiction of the global nephrostomy device industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global nephrostomy device market share.
  • The current market is quantitatively analyzed to highlight the global Nephrostomy Device market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the Nephrostomy Device market.
  • The report provides a detailed global nephrostomy device market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the nephrostomy device market research report:

  • Which are the leading market players active in the Nephrostomy Device market?
  • What current trends will influence the Nephrostomy Device market in the next few years?
  • What are the driving factors, restraints, and opportunities in the Nephrostomy Device market?
  • What are the projections for the future that would help in tasking further strategic steps?

 Nephrostomy Device Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Product Type
  • Guidewires
  • Drainage Tubes
  • Sheath Dilators
  • Nephrostomy Catheters
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, Italy, UK, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Smith & Nephew, Cardinal Health, Coloplast Group, Boston Scientific Corporation, Uresil LLC, B. Braun Melsungen AG, Becton, Dickinson and Company, Olympus Corp, Teleflex Incorporated, Cook Medical
Other Players Stryker Corporation
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEPHROSTOMY DEVICE MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Guidewires

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Drainage Tubes

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Sheath Dilators

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Nephrostomy Catheters

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: NEPHROSTOMY DEVICE MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ambulatory Surgical Centers

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Other

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: NEPHROSTOMY DEVICE MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product Type

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Nephrostomy Device Market

        • 6.2.5.1. Market Size and Forecast, By Product Type
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Nephrostomy Device Market

        • 6.2.6.1. Market Size and Forecast, By Product Type
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Nephrostomy Device Market

        • 6.2.7.1. Market Size and Forecast, By Product Type
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product Type

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Nephrostomy Device Market

        • 6.3.5.1. Market Size and Forecast, By Product Type
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Nephrostomy Device Market

        • 6.3.6.1. Market Size and Forecast, By Product Type
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Nephrostomy Device Market

        • 6.3.7.1. Market Size and Forecast, By Product Type
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Nephrostomy Device Market

        • 6.3.8.1. Market Size and Forecast, By Product Type
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Nephrostomy Device Market

        • 6.3.9.1. Market Size and Forecast, By Product Type
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Nephrostomy Device Market

        • 6.3.10.1. Market Size and Forecast, By Product Type
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Nephrostomy Device Market

        • 6.3.11.1. Market Size and Forecast, By Product Type
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product Type

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Nephrostomy Device Market

        • 6.4.5.1. Market Size and Forecast, By Product Type
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Nephrostomy Device Market

        • 6.4.6.1. Market Size and Forecast, By Product Type
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Nephrostomy Device Market

        • 6.4.7.1. Market Size and Forecast, By Product Type
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Nephrostomy Device Market

        • 6.4.8.1. Market Size and Forecast, By Product Type
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Nephrostomy Device Market

        • 6.4.9.1. Market Size and Forecast, By Product Type
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Nephrostomy Device Market

        • 6.4.10.1. Market Size and Forecast, By Product Type
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Nephrostomy Device Market

        • 6.4.11.1. Market Size and Forecast, By Product Type
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Nephrostomy Device Market

        • 6.4.12.1. Market Size and Forecast, By Product Type
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Nephrostomy Device Market

        • 6.4.13.1. Market Size and Forecast, By Product Type
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product Type

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Nephrostomy Device Market

        • 6.5.5.1. Market Size and Forecast, By Product Type
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Nephrostomy Device Market

        • 6.5.6.1. Market Size and Forecast, By Product Type
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Nephrostomy Device Market

        • 6.5.7.1. Market Size and Forecast, By Product Type
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Nephrostomy Device Market

        • 6.5.8.1. Market Size and Forecast, By Product Type
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Nephrostomy Device Market

        • 6.5.9.1. Market Size and Forecast, By Product Type
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Nephrostomy Device Market

        • 6.5.10.1. Market Size and Forecast, By Product Type
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Cardinal Health

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Cook Medical

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Teleflex Incorporated

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Boston Scientific Corporation

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. B. Braun Melsungen AG

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Becton, Dickinson And Company

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Coloplast Group

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Uresil LLC

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Olympus Corp

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Smith And Nephew

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEPHROSTOMY DEVICE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEPHROSTOMY DEVICE MARKET FOR GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEPHROSTOMY DEVICE MARKET FOR DRAINAGE TUBES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEPHROSTOMY DEVICE MARKET FOR SHEATH DILATORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEPHROSTOMY DEVICE MARKET FOR NEPHROSTOMY CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEPHROSTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEPHROSTOMY DEVICE MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NEPHROSTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NEPHROSTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NEPHROSTOMY DEVICE MARKET FOR OTHER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NEPHROSTOMY DEVICE MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. NORTH AMERICA NEPHROSTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 15. U.S. NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 16. U.S. NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. CANADA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 18. CANADA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 19. MEXICO NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 20. MEXICO NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. EUROPE NEPHROSTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. EUROPE NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 23. EUROPE NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 25. FRANCE NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. GERMANY NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. GERMANY NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 28. ITALY NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 29. ITALY NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. SPAIN NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. UK NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 33. UK NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. RUSSIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. RUSSIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. REST OF EUROPE NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. REST OF EUROPE NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. ASIA-PACIFIC NEPHROSTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. ASIA-PACIFIC NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 40. ASIA-PACIFIC NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. CHINA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 42. CHINA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. JAPAN NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 44. JAPAN NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. INDIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 46. INDIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. SOUTH KOREA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. SOUTH KOREA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. AUSTRALIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 50. AUSTRALIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. THAILAND NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. THAILAND NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. MALAYSIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 54. MALAYSIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. INDONESIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. INDONESIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. REST OF ASIA PACIFIC NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. REST OF ASIA PACIFIC NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. LAMEA NEPHROSTOMY DEVICE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 60. LAMEA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 61. LAMEA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. BRAZIL NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. BRAZIL NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 66. SAUDI ARABIA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SAUDI ARABIA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. UAE NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 69. UAE NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. ARGENTINA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 71. ARGENTINA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. REST OF LAMEA NEPHROSTOMY DEVICE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. REST OF LAMEA NEPHROSTOMY DEVICE, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. CARDINAL HEALTH: KEY EXECUTIVES
  • TABLE 75. CARDINAL HEALTH: COMPANY SNAPSHOT
  • TABLE 76. CARDINAL HEALTH: OPERATING SEGMENTS
  • TABLE 77. CARDINAL HEALTH: PRODUCT PORTFOLIO
  • TABLE 78. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 79. COOK MEDICAL: KEY EXECUTIVES
  • TABLE 80. COOK MEDICAL: COMPANY SNAPSHOT
  • TABLE 81. COOK MEDICAL: OPERATING SEGMENTS
  • TABLE 82. COOK MEDICAL: PRODUCT PORTFOLIO
  • TABLE 83. COOK MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 84. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 85. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 86. TELEFLEX INCORPORATED: OPERATING SEGMENTS
  • TABLE 87. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 88. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 89. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 90. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 92. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 93. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 94. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 95. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 96. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 97. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 98. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 99. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 100. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 101. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 102. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 103. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 104. COLOPLAST GROUP: KEY EXECUTIVES
  • TABLE 105. COLOPLAST GROUP: COMPANY SNAPSHOT
  • TABLE 106. COLOPLAST GROUP: OPERATING SEGMENTS
  • TABLE 107. COLOPLAST GROUP: PRODUCT PORTFOLIO
  • TABLE 108. COLOPLAST GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. URESIL LLC: KEY EXECUTIVES
  • TABLE 110. URESIL LLC: COMPANY SNAPSHOT
  • TABLE 111. URESIL LLC: OPERATING SEGMENTS
  • TABLE 112. URESIL LLC: PRODUCT PORTFOLIO
  • TABLE 113. URESIL LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. OLYMPUS CORP: KEY EXECUTIVES
  • TABLE 115. OLYMPUS CORP: COMPANY SNAPSHOT
  • TABLE 116. OLYMPUS CORP: OPERATING SEGMENTS
  • TABLE 117. OLYMPUS CORP: PRODUCT PORTFOLIO
  • TABLE 118. OLYMPUS CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. SMITH AND NEPHEW: KEY EXECUTIVES
  • TABLE 120. SMITH AND NEPHEW: COMPANY SNAPSHOT
  • TABLE 121. SMITH AND NEPHEW: OPERATING SEGMENTS
  • TABLE 122. SMITH AND NEPHEW: PRODUCT PORTFOLIO
  • TABLE 123. SMITH AND NEPHEW: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROSTOMY DEVICE MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEPHROSTOMY DEVICE MARKET
  • FIGURE 3. SEGMENTATION NEPHROSTOMY DEVICE MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEPHROSTOMY DEVICE MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEPHROSTOMY DEVICE MARKET
  • FIGURE 11. NEPHROSTOMY DEVICE MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. NEPHROSTOMY DEVICE MARKET FOR GUIDEWIRES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEPHROSTOMY DEVICE MARKET FOR DRAINAGE TUBES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEPHROSTOMY DEVICE MARKET FOR SHEATH DILATORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. NEPHROSTOMY DEVICE MARKET FOR NEPHROSTOMY CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NEPHROSTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NEPHROSTOMY DEVICE MARKET SEGMENTATION, BY BY END USER
  • FIGURE 18. NEPHROSTOMY DEVICE MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NEPHROSTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. NEPHROSTOMY DEVICE MARKET FOR OTHER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 25. COMPETITIVE DASHBOARD
  • FIGURE 26. COMPETITIVE HEATMAP: NEPHROSTOMY DEVICE MARKET
  • FIGURE 27. Top player positioning, 2022
  • FIGURE 28. CARDINAL HEALTH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. COOK MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. COOK MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. COOK MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. TELEFLEX INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. BECTON, DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. COLOPLAST GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. COLOPLAST GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. COLOPLAST GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. URESIL LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. URESIL LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. URESIL LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. OLYMPUS CORP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. OLYMPUS CORP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. OLYMPUS CORP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. SMITH AND NEPHEW: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. SMITH AND NEPHEW: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. SMITH AND NEPHEW: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Nephrostomy Device Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers